Mould, Daniel P <br/><br/>
Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1.  [electronic resource] 

 -  Journal of medicinal chemistry  10 2017 
 - 7984-7999 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1520-4804 
<br/><br/><label>Standard No.: </label>10.1021/acs.jmedchem.7b00462  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--chemical synthesis<br/>Biomarkers<br/>Cell Line, Tumor<br/>Computer Simulation<br/>Drug Design<br/>Drug Discovery<br/>Enzyme Inhibitors--chemical synthesis<br/>Ether-A-Go-Go Potassium Channels--drug effects<br/>Glycine--analogs & derivatives<br/>High-Throughput Screening Assays<br/>Histone Demethylases--antagonists & inhibitors<br/>Humans<br/>Leukemia--drug therapy<br/>Models, Molecular<br/>Molecular Docking Simulation<br/>Spiro Compounds--chemical synthesis<br/>Structure-Activity Relationship<br/>Tranylcypromine--analogs & derivatives